{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:27:20Z","timestamp":1753892840988,"version":"3.41.2"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016297","name":"Geisinger Commonwealth School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Substance Use Disorder (SUD) screening tools used in current practice are designed to identify SUD once patients have begun regular dangerous drug use. While these screening tools are valuable, prevention and avoidance of SUD would save countless lives. The climbing number of deaths due to drug overdose make screening for and prevention of SUD imperative. This study addresses this care gap. The aim was to develop a simple screening tool for patients who may be prone to develop Alcohol Use Disorder (AUD) and\/or SUD prior to addiction. It was hypothesized that participants with initially positive emotional experiences would be correlated with a future SUD diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study involved a self-administered survey using a cross-sectional design and was carried out over one-month in the spring of 2021. Those patients who presented to the MAT clinic (SUD group) were seen in a separate area than the patients presenting for urgent care (Comparison group). Participants (N\u00a0=\u00a0259) were voluntarily recruited from MAT and Urgent care: Patients receiving acute care were assigned to the Comparison (N = 126, 50.8% female, 5.7% non-white, 27.2% age &amp;lt; 34) and those receiving treatment for SUD were assigned to the MAT group (N =133, 40.8% female, 4.8% non-white, 36.8% \u226434). The survey questioned demographics (4 items), risk factors for AUD\/SUD (6\u00a0items), information about first alcohol\/opioid experiences (16 items), and factors for seeking AUD\/SUD treatment and recovery (2 items). Feelings were categorized as positive (e.g., euphoria, happiness, self-confident), neutral (e.g., nothing, normal), or negative (e.g., depressed, sad, sick).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The MAT group felt more positive feelings with first usage of alcohol and opioids compared to the comparison group (p&amp;lt;.001). With first usage of opioids specifically, MAT (0.13 \u00b1 0.04) and comparison (0.29 \u00b1 0.07) groups differed (p &amp;lt;.001). Over half (55.3%), of the MAT participants reported feeling self-confident with first use of alcohol while only 29.7% of the comparison reported this (p&amp;lt;.001). Over three-fifths (63.7%) of the MAT group reported feeling of euphoria with the first usage of opioids compared to one-tenth (9.8%) in the comparison group (p&amp;lt;.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This retrospective cross-sectional report shows the first affective responses to substances may predict risk for future SUD and could be a prevention screening tool. Asking patients about positive feelings with first usage of alcohol\/opioids could be a simple screening tool employed for prevention.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2024.1368598","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T15:43:29Z","timestamp":1726847009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Substance use disorder risk assessment: positive emotional experiences with first time use and substance use disorder risk"],"prefix":"10.3389","volume":"15","author":[{"given":"Karen E.","family":"Arscott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna M.","family":"Eget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Piper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2016.03.014","article-title":"Understanding the demand side of the prescription opioid epidemic: Does the initial source of opioids matter","volume":"173","author":"Cicero","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.252.14.1905","article-title":"Detecting alcoholism. the cage questionnaire","volume":"252","author":"Ewing","year":"1984","journal-title":"JAMA"},{"key":"B3","article-title":"The Michigan Alcoholism Screening Test (MAST): A comprehensive review","volume":"15","author":"Hedlund","year":"1984","journal-title":"J Operational Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(83)90071-6","article-title":"Validity and reliability of the Michigan Alcoholism Screening Test: A review","volume":"12","author":"Gibbs","year":"1983","journal-title":"Drug Alcohol Dependence"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.1995.56.423","article-title":"The Alcohol Use Disorders Identification Test (audit): Validation of a screening instrument for use in medical settings","volume":"56","author":"Bohn","year":"1995","journal-title":"J Stud Alcohol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.01.014","article-title":"Development and validation of the current opioid misuse measure","volume":"130","author":"Butler","year":"2007","journal-title":"Pain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/2F1078345814557513","article-title":"Validation of a brief measure of opioid dependence","volume":"21","author":"Wickersham","year":"2015","journal-title":"J Correctional Health Care"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2009.11.005","article-title":"Psychometric validation of the Leeds Dependence Questionnaire (LDQ) in a young adult clinical sample","volume":"35","author":"Kelly","year":"2010","journal-title":"Addictive Behaviors"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7326\/m16-0317","article-title":"Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients","volume":"165","author":"McNeely","year":"2016","journal-title":"Ann Internal Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00131","article-title":"Alcohol screening and brief intervention in workplace settings and social services: A comparison of literature","volume":"5","author":"Schulte","year":"2014","journal-title":"Front Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamapsychiatry.2022.1652","article-title":"Preaddiction\u2014a missing concept for treating substance use disorders","volume":"79","author":"McLellan","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"B13","article-title":"Provisional drug overdose death counts","volume-title":"Natl Center Health Stat","author":"Ahmad","year":"2024"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7308a1","article-title":"Deaths from Excessive Alcohol Use \u2014 United States, 2016\u20132021","volume-title":"MMWR Morb Mortal Wkly Rep","author":"Esser","year":"2024"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"B16","article-title":"Alcohol use disorder: pharmacologic treatment options","volume":"102","author":"Groves","year":"2020","journal-title":"Am Fam Physician"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.dcn.2016.10.004","article-title":"Sensitive periods of substance abuse: early risk for the transition to dependence","volume":"25","author":"Jordan","year":"2017","journal-title":"Dev Cogn Neurosci"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1368598\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T15:43:32Z","timestamp":1726847012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1368598\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":17,"alternative-id":["10.3389\/fpsyt.2024.1368598"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1368598","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"article-number":"1368598"}}